1. Home
  2. EBON vs ATHA Comparison

EBON vs ATHA Comparison

Compare EBON & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

HOLD

Current Price

$3.50

Market Cap

21.4M

Sector

Technology

ML Signal

HOLD

Logo Athira Pharma Inc.

ATHA

Athira Pharma Inc.

HOLD

Current Price

$7.15

Market Cap

18.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBON
ATHA
Founded
2010
2011
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.4M
18.2M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
EBON
ATHA
Price
$3.50
$7.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.1K
3.1M
Earning Date
08-15-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,337,066.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
104.28
N/A
52 Week Low
$3.00
$2.20
52 Week High
$7.15
$8.36

Technical Indicators

Market Signals
Indicator
EBON
ATHA
Relative Strength Index (RSI) 38.20 83.94
Support Level $3.31 $3.80
Resistance Level $3.63 $8.36
Average True Range (ATR) 0.18 0.39
MACD 0.02 0.27
Stochastic Oscillator 11.12 66.23

Price Performance

Historical Comparison
EBON
ATHA

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.

Share on Social Networks: